N,N-二丙基乙酰胺 | 1116-24-1

• 物质功能分类: 化学试剂 - 有机试剂 - 酰胺
• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 中文名称: N,N-二丙基乙酰胺
• 中文别名: 癫健安
• 英文名称: N,N-dipropylacetamide
• 英文别名: N,N-Dipropyl-acetamid；N,N-Di-n-propyl-acetamid；Dipropylacetamid；N,N-di-n-propylacetamide
• CAS: 1116-24-1
• 化学式: C₈H₁₇NO
• mdl: MFCD00051358
• 分子量: 143.229
• InChiKey: IFTIBNDWGNYRLS-UHFFFAOYSA-N

物化性质

• 沸点：
  87 °C (6 mmHg)
• 密度：
  0.89
• 闪点：
  88 °C
• 稳定性/保质期：
  在常温常压下，该物质是稳定的。

计算性质

• 辛醇/水分配系数(LogP)：
  1.5
• 重原子数：
  10
• 可旋转键数：
  4
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.875
• 拓扑面积：
  20.3
• 氢给体数：
  0
• 氢受体数：
  1

安全信息

• 危险品标志：
  C
• 安全说明：
  S26,S28A
• 危险类别码：
  R34
• 海关编码：
  2924199090
• 储存条件：
  密封储存，存放在室温和干燥的库房中，并远离腐蚀性区域。

SDS

Name:	N N-Dipropylacetamide 99+% (GC) Material Safety Data Sheet
Synonym:	None
CAS:	1116-24-1

Section 1 - Chemical Product MSDS Name:N N-Dipropylacetamide 99+% (GC) Material Safety Data Sheet
Synonym:None

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
1116-24-1	Acetamide, N,N-Dipropyl-	>99	214-234-8

Hazard Symbols: C
Risk Phrases: 34

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Causes burns.Corrosive.
Potential Health Effects
Eye:
Causes eye burns. May cause chemical conjunctivitis and corneal damage.
Skin:
Causes skin burns. May cause cyanosis of the extremities. May cause skin rash (in milder cases), and cold and clammy skin with cyanosis or pale color.
Ingestion:
May cause severe and permanent damage to the digestive tract. May cause gastrointestinal irritation with nausea, vomiting and diarrhea. Causes gastrointestinal tract burns. May cause perforation of the digestive tract. May cause systemic effects.
Inhalation:
Causes chemical burns to the respiratory tract. Aspiration may lead to pulmonary edema. May cause systemic effects. Inhalation at high concentrations may cause CNS depression and asphixiation.
Chronic:
Effects may be delayed.

---

Section 4 - FIRST AID MEASURES
Eyes: Get medical aid immediately. Do NOT allow victim to rub eyes or keep eyes closed. Extensive irrigation with water is required (at least 30 minutes).
Skin:
Get medical aid immediately. Immediately flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse. Destroy contaminated shoes.
Ingestion:
Do not induce vomiting. If victim is conscious and alert, give 2-4 cupfuls of milk or water. Get medical aid immediately.
Inhalation:
Get medical aid immediately. Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Do NOT use mouth-to-mouth resuscitation. If breathing has ceased apply artificial respiration using oxygen and a suitable mechanical device such as a bag and a mask.
Notes to Physician:

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion. Use water spray to keep fire-exposed containers cool. Water may be ineffective.
Material is lighter than water and a fire may be spread by the use of water. Combustible liquid. Vapors may be heavier than air. They can spread along the ground and collect in low or confined areas.
Containers may explode when heated.
Extinguishing Media:
In case of fire, use water, dry chemical, chemical foam, or alcohol-resistant foam. Use water spray to cool fire-exposed containers. Water may be ineffective.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Absorb spill with inert material (e.g. vermiculite, sand or earth), then place in suitable container. Avoid runoff into storm sewers and ditches which lead to waterways. Clean up spills immediately, observing precautions in the Protective Equipment section. Remove all sources of ignition. Use a spark-proof tool. Provide ventilation.

---

Section 7 - HANDLING and STORAGE
Handling:
Wash thoroughly after handling. Remove contaminated clothing and wash before reuse. Use only in a well-ventilated area. Avoid contact with eyes, skin, and clothing. Empty containers retain product residue, (liquid and/or vapor), and can be dangerous. Keep container tightly closed. Keep away from heat, sparks and flame. Avoid ingestion and inhalation. Discard contaminated shoes. Do not pressurize, cut, weld, braze, solder, drill, grind, or expose empty containers to heat, sparks or open flames.
Storage:
Keep away from heat, sparks, and flame. Keep away from sources of ignition. Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances. Corrosives area.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 1116-24-1: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Liquid
Color: colorless
Odor: acetic odor
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: 87 deg C @ 6.00mm Hg
Freezing/Melting Point: Not available.
Autoignition Temperature: Not available.
Flash Point: 88 deg C ( 190.40 deg F)
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density: .8900g/cm3
Molecular Formula: C8H17NO
Molecular Weight: 143.23

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Incompatible materials, ignition sources, excess heat, strong oxidants.
Incompatibilities with Other Materials:
Strong oxidizing agents.
Hazardous Decomposition Products:
Carbon monoxide, oxides of nitrogen, irritating and toxic fumes and gases, carbon dioxide.
Hazardous Polymerization: Has not been reported

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 1116-24-1 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
Acetamide, N,N-Dipropyl- - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
Shipping Name: CORROSIVE LIQUID, N.O.S.*
Hazard Class: 8
UN Number: 1760
Packing Group: III
IMO
Shipping Name: CORROSIVE LIQUID, N.O.S.
Hazard Class: 8
UN Number: 1760
Packing Group: III
RID/ADR
Shipping Name: CORROSIVE LIQUID, N.O.S.
Hazard Class: 8
UN Number: 1760
Packing group: III

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: C
Risk Phrases:
R 34 Causes burns.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 28A After contact with skin, wash immediately with
plenty of water.
WGK (Water Danger/Protection)
CAS# 1116-24-1: No information available.
Canada
CAS# 1116-24-1 is listed on Canada's NDSL List.
CAS# 1116-24-1 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 1116-24-1 is listed on the TSCA inventory.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

制备方法与用途

用途：用于医药工业。

反应信息

• 作为反应物：
  描述：

  N,N-二丙基乙酰胺 在 氢气 作用下， 以 乙二醇二甲醚 为溶剂， 160.0 ℃ 、3.0 MPa 条件下， 反应 20.0h， 生成 N-乙基二丙胺
  参考文献：
  名称：

  在温和条件下将酰胺催化加氢为胺

  摘要：

  在（不是很大）压力下：已开发出一种使用双金属Pd-Re催化剂将叔酰胺和仲酰胺氢化成胺的通用方法，具有优异的选择性。反应在低压和较低温度下进行。该方法为有机化学家提供了一种简单可靠的胺合成工具。

  DOI：

  10.1002/anie.201207803
• 作为产物：
  描述：

  dipropylammonium dipropylcarbamate 以 二氯甲烷 为溶剂， 反应 0.75h， 生成 N,N-二丙基乙酰胺
  参考文献：
  名称：

  三甲基甲硅烷基化的N-烷基取代的氨基甲酸酯I.制备及一些反应

  摘要：

  三甲基甲硅烷Ñ -monoalkyl-和Ñ，Ñ二烷基-氨基甲酸酯已在85-95％的收率由相应的氨基甲酸铵与三甲基氯硅烷的甲硅烷基化制备。三甲基甲硅烷基N N-二甲基氨基甲酸酯可用于醇，酚和羧酸的甲硅烷基化。甲硅烷基氨基甲酸酯与羧酸卤化物反应，得到相应的酸酰胺。氨基甲酸三甲基甲硅烷基酯与羧酸酐的反应生成相应的甲硅烷基羧酸酯和酰胺，而与二羧酸酐的反应生成相应的二羧酸的三甲基甲硅烷基单酰胺，即Me 3 SiO 2 -CCONR 1 R2。

  DOI：

  10.1016/s0022-328x(00)99291-x

文献信息

• Direct Preparation of Amides from Amine Hydrochloride Salts and Orthoesters: A Synthetic and Mechanistic Perspective
  作者：Martin J. Di Grandi、Caitlin Bennett、Kristen Cagino、Arnold Muccini、Corey Suraci、Shahrokh Saba

  DOI：10.1080/00397911.2015.1096943

  日期：2015.11.17

  Abstract The conversion of a wide range of primary and secondary aliphatic and a few arylamine hydrochloride salts to their corresponding acetamides with trimethyl orthoacetate is described. Mechanistic studies using NMR and gas chromatography–mass spectrometry techniques indicate these reactions proceed via an O-methylimidate intermediate that undergoes in situ demethylation by chloride, affording

  摘要 描述了使用原乙酸三甲酯将范围广泛的伯、仲脂肪族盐和一些芳胺盐酸盐转化为相应的乙酰胺。使用 NMR 和气相色谱-质谱技术的机理研究表明，这些反应是通过 O-甲基亚氨酸酯中间体进行的，该中间体通过氯化物进行原位去甲基化，得到相应的乙酰胺。从合成上讲，该反应代表了一种实用的、高产率的方案，只需简单的后处理即可将胺盐酸盐快速转化为乙酰胺。图形概要
• [EN] QUINAZOLINE COMPOUNDS<br/>[FR] COMPOSÉS QUINAZOLÉINE
  申请人：CANCER REC TECH LTD

  公开号：WO2015079251A1

  公开（公告）日：2015-06-04

  The present invention relates to quinazoline compounds of formula I that function as inhibitors of RET (rearranged during transfection) kinase enzyme activity: (Formula (I)) wherein X, R1, R2, R3, R4, R5, R6 and R7 are each as defined herein. The present invention also relates to processes for the preparation of these compounds, to pharmaceutical compositions comprising them, and to their use in the treatment of proliferative disorders, such as cancer, as well as other diseases or conditions in which RET kinase activity is implicated.

  本发明涉及式I的喹唑啉化合物，其作为RET（重排基因转座）激酶酶活性的抑制剂：（式（I）），其中X，R1，R2，R3，R4，R5，R6和R7如本文所定义。本发明还涉及制备这些化合物的方法，包括它们的药物组合物，以及它们在治疗增殖性疾病（如癌症）以及其他涉及RET激酶活性的疾病或症状中的用途。
• [EN] 1,3,4-OXADIAZOLE SULFAMIDE DERIVATIVE COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITOR, AND THE PHARMACEUTICAL COMPOSITION COMPRISING THE SAME<br/>[FR] COMPOSÉS DÉRIVÉS DE SULFAMIDE DU 1,3,4-OXADIAZOLE UTILISÉS COMME INHIBITEUR DE L'HISTONE DÉSACÉTYLASE 6, ET COMPOSITION PHARMACEUTIQUE COMPRENANT CEUX-CI
  申请人：CHONG KUN DANG PHARMACEUTICAL CORP

  公开号：WO2017018805A1

  公开（公告）日：2017-02-02

  The present invention relates to novel compounds having histone deacetylase 6 (HDAC6) inhibitory activity, stereoisomers thereof or pharmaceutically acceptable salts thereof, the use thereof for the preparation of therapeutic medicaments, pharmaceutical compositions containing the same, a method for treating diseases using the composition, and methods for preparing the novel compounds. The novel compounds, stereoisomers thereof or pharmaceutically acceptable salts thereof according to the present invention have histone deacetylase (HDAC) inhibitory activity and are effective for the prevention or treatment of HDAC6-mediated diseases, including infectious diseases; neoplasms; endocrine, nutritional and metabolic diseases; mental and behavioral disorders; neurological diseases; diseases of the eye and adnexa; cardiovascular diseases; respiratory diseases; digestive diseases; diseases of the skin and subcutaneous tissue; diseases of the musculoskeletal system and connective tissue; or congenital malformations, deformations and chromosomal abnormalities.

  本发明涉及具有组蛋白去乙酰化酶6（HDAC6）抑制活性的新化合物，其立体异构体或其药学上可接受的盐，其用于制备治疗药物，含有相同化合物的药物组合物，使用该组合物治疗疾病的方法，以及制备新化合物的方法。根据本发明，所述新化合物，其立体异构体或其药学上可接受的盐具有组蛋白去乙酰化酶（HDAC）抑制活性，并且对于预防或治疗HDAC6介导的疾病具有有效性，包括传染病；肿瘤；内分泌、营养和代谢疾病；精神和行为障碍；神经系统疾病；眼及其附器疾病；心血管疾病；呼吸系统疾病；消化系统疾病；皮肤和皮下组织疾病；肌肉骨骼系统和结缔组织疾病；或先天畸形、变形和染色体异常。
• Process for making n-(diphenylmethyl)piperazines
  申请人：Zhu Jie

  公开号：US20090143582A1

  公开（公告）日：2009-06-04

  The compound of formula (8), in racemic or single enantiomeric form, is useful in making N-(diphenylmethyl)-piperazines such as cetirizine and levocetrizine. wherein Z is preferably phenyl.

  公式（8）的化合物，无论是消旋体还是单对映体形式，对制备N-（二苯甲基）-哌嗪类化合物如西替利嗪和左西替利嗪很有用。 其中Z最好是苯基。
• PROCESS FOR MAKING N-(DIPHENYLMETHYL)PIPERAZINES
  申请人：Zhu Jie

  公开号：US20100145049A1

  公开（公告）日：2010-06-10

  A compound of formula (8) or a salt thereof: wherein Z represents a group containing 1-20 carbon atoms and at least one chiral carbon atom and having a single conformation, is useful in the synthesis of pharmaceutical compounds, especially chiral compounds such as levocetirizine.

  式（8）的化合物或其盐： 其中Z代表含有1-20个碳原子且至少一个手性碳原子且具有单一构象的基团，在制备药物化合物，特别是手性化合物如左西替利嗪方面是有用的。

表征谱图